Virijevic, M.; Jakovic, L.; Trajkovic, L.; Cvetkovic, M.; Pravdic, Z.; Mitrovic, M.; Suvajdzic-Vukovic, N.; Bogdanovic, A.
Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R. Medicina 2025, 61, 1689.
https://doi.org/10.3390/medicina61091689
AMA Style
Virijevic M, Jakovic L, Trajkovic L, Cvetkovic M, Pravdic Z, Mitrovic M, Suvajdzic-Vukovic N, Bogdanovic A.
Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R. Medicina. 2025; 61(9):1689.
https://doi.org/10.3390/medicina61091689
Chicago/Turabian Style
Virijevic, Marijana, Ljubomir Jakovic, Lazar Trajkovic, Mirjana Cvetkovic, Zlatko Pravdic, Mirjana Mitrovic, Nada Suvajdzic-Vukovic, and Andrija Bogdanovic.
2025. "Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R" Medicina 61, no. 9: 1689.
https://doi.org/10.3390/medicina61091689
APA Style
Virijevic, M., Jakovic, L., Trajkovic, L., Cvetkovic, M., Pravdic, Z., Mitrovic, M., Suvajdzic-Vukovic, N., & Bogdanovic, A.
(2025). Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R. Medicina, 61(9), 1689.
https://doi.org/10.3390/medicina61091689